Skip to main content

Advertisement

SpringerLink
Log in

The Women’s Health Initiative Study: Perspectives and Implications for Clinical Practice

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321–333.

    Google Scholar 

  2. Women’s Health Initiative Steering Committee. The effects of conjugated equine estrogen in postmenopausal women with hysterectomy (The Women’s Health Initiative randomized, controlled, trial). JAMA 2004;291:1701–1712.

    Google Scholar 

  3. Shumaker SA, Legault C, Rapp SR, Thail, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J;WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Study: A randomized controlled trial. JAMA 2003;289:2651–2662.

    Google Scholar 

  4. Blake JM, Collins JA, Reid RL, Fedorkow DM, Lalonde AB, Christilaw J, Fortier M, Fortin C, Jolly EE, Lemay A, O’Grady T, Smith TE, Cooper J, Maxted JM, O’Grady K, Turek MA;SOGC (Society of Obstetricians and Gynaecologists of Canada). The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women. J Obstet Gynecol Can 2002;24(10):783–787.

    Google Scholar 

  5. Response to the Women’s Health Initiative Study results by the American College of Obstetricians and Gynecologists. ACOG.net 2002; August 2002.

  6. Schneider, Herman PG. The view of the International Menopause Society on the Women’s Health Initiative, 2002.

  7. Amended report from NAMS Advisory Panel on Postmenopausal Hormone Therapy. Advisory Panel Report. Menopause 2003;10:6–12.

    Google Scholar 

  8. ACOG Statement on the NIH announcement to halt the estrogen-only arm of the WHI study. ACOG.net 2004; March 2004.

  9. ASRM Statement on Suspension of the WHI Trial. Infertility Resources, Internet Health Resources 2004; March 2004.

  10. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995;38:199–210.

    Google Scholar 

  11. LHodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP. Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;35:939–953.

    Google Scholar 

  12. Hanke H, Kamenz J, Hanke S, Spiess J, Lenz C, Brehme U, Bruck B, Finking G, Hombach V. Effect of 17-β estradiol on pre-existing atherosclerotic lesions: Role of the endothelium. Atherosclerosis 1999;147:123–132.

    Google Scholar 

  13. Holm P, Andersen HL, Andersen MR, Erhardtsen E, Stender S. The direct atherogenic effect of estrogen is present, absent or reversed, depending on the state of the arterial endothelium. Circulation 1999;100:1727–1733.

    Google Scholar 

  14. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factor in post-menopausal women: The PEPI Trial. JAMA 1995;273:199–208.

    Google Scholar 

  15. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–1811.

    Google Scholar 

  16. Adams MR,Washburn SA,Wagner JA,Williams JK, Clarkson TB. Aterial changes: Estrogen deficiency and the effects of hormone replacement. In Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1999:377–384.

    Google Scholar 

  17. Karas RH, Clarkson TB. Menopausal Medicine 2003;10:9–12.

    Google Scholar 

  18. Manson JE, Hsai J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M for the Women’s Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523–534.

    Google Scholar 

  19. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith SC Jr, Taubert KA, Wenger NK;American Heart Association. Hormone replacement therapy and cardiovascular disease: A Statement for health care professionals from the American Heart Association. Circulation 2001;104:499–503.

    Google Scholar 

  20. Mendelsohn ME, Karas RH. The time has come to stop letting the HERS tale wag the dogma. Circulation 2001;104(19):2256–2259.

    Google Scholar 

  21. Leblanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: Systematic review and data analysis. JAMA 2001;295:1489–1499.

    Google Scholar 

  22. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485–495.

    Google Scholar 

  23. Sherwin BB, Tulandi T. “Add-Back“ estrogen reverses cognitive defects induced by GnRH agonists in women with leiomyomata uteri. J Clin Endocrinol Metab 1996;81:2545–2549.

    Google Scholar 

  24. Shaywitz SE, Naftolin F, Zelterman D, Marchione KE, Holahan JM, Palter SF, Shaywitz BA. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause 2003;10:420–426.

    Google Scholar 

  25. Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: The Heart and Estrogen/Progestin Study. Am J Med 2002;113:543–548.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. EC Hamblen Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina

    Charles B. Hammond

  2. Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina

    Charles B. Hammond

Authors
  1. Charles B. Hammond
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles B. Hammond.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hammond, C.B. The Women’s Health Initiative Study: Perspectives and Implications for Clinical Practice. Rev Endocr Metab Disord 6, 93–99 (2005). https://doi.org/10.1007/s11154-005-6721-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-005-6721-x

Key words

Search

Navigation